Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FORG
3101
PUT
DELISTED
ForgeRock, Inc.
FORG
| $2.88M | ﹤0.01% |
140,300
+89,300
| +175% | +$1.79M |
|
3102
Skyworks Solutions
SWKS
$9.37B
| $2.88M | ﹤0.01% |
26,007
-930,144
| -97% | -$98.1M |
|
3103
Southwest Gas
SWX
$6.47B
| $2.88M | ﹤0.01% |
45,181
+39,481
| +693% | +$2.33M |
|
3104
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| $2.87M | ﹤0.01% |
381,800
+1,000
| +0.3% | +$8.11K |
|
|
VRTV
3105
DELISTED
VERITIV CORPORATION
VRTV
| $2.87M | ﹤0.01% |
22,881
-44,377
| -66% | -$5.19M |
|
3106
Richardson Electronics
RELL
$267M
| $2.87M | ﹤0.01% |
174,130
-276,956
| -61% | -$4.79M |
|
3107
Skyward Specialty Insurance
SKWD
$2.43B
| $2.87M | ﹤0.01% |
112,974
+20,218
| +22% | +$467K |
|
3108
CALL
Estee Lauder
EL
$30.4B
| $2.87M | ﹤0.01% |
14,600
-13,100
| -47% | -$2.78M |
|
3109
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $2.86M | ﹤0.01% |
+33,100
| New | +$2.83M |
|
3110
AZZ Inc
AZZ
$4.35B
| $2.86M | ﹤0.01% |
65,847
+23,676
| +56% | +$909K |
|
3111
Progress Software
PRGS
$1.66B
| $2.86M | ﹤0.01% |
49,242
+38,906
| +376% | +$2.21M |
|
3112
CALL
Campbell Soup
CPB
$6.55B
| $2.86M | ﹤0.01% |
62,500
+51,500
| +468% | +$2.66M |
|
3113
Haemonetics
HAE
$3.89B
| $2.86M | ﹤0.01% |
33,552
+20,670
| +160% | +$1.75M |
|
3114
TD Synnex
SNX
$20.4B
| $2.85M | ﹤0.01% |
30,351
-513,153
| -94% | -$47M |
|
3115
CS Disco
LAW
$250M
| $2.85M | ﹤0.01% |
347,058
-10,805
| -3% | -$74.1K |
|
3116
ArcelorMittal
MT
$52.9B
| $2.85M | ﹤0.01% |
104,246
-57,998
| -36% | -$1.59M |
|
3117
Evertec
EVTC
$1.88B
| $2.84M | ﹤0.01% |
77,143
-137,384
| -64% | -$4.76M |
|
3118
CALL
Green Plains
GPRE
$1.18B
| $2.84M | ﹤0.01% |
+88,000
| New | +$2.79M |
|
3119
CALL
Flywire
FLYW
$1.98B
| $2.84M | ﹤0.01% |
+91,400
| New | +$2.74M |
|
3120
CALL
CRISPR Therapeutics
CRSP
$4.73B
| $2.84M | ﹤0.01% |
50,500
+20,500
| +68% | +$1.16M |
|
|
SKX
3121
PUT
DELISTED
Skechers
SKX
| $2.83M | ﹤0.01% |
+53,800
| New | +$2.75M |
|
3122
CALL
Camden Property Trust
CPT
$11B
| $2.83M | ﹤0.01% |
26,000
+5,000
| +24% | +$539K |
|
|
3123
PUT
Green Plains
GPRE
$1.18B
| $2.82M | ﹤0.01% |
+87,600
| New | +$2.77M |
|
3124
Neuropace
NPCE
$439M
| $2.82M | ﹤0.01% |
628,933
-102,677
| -14% | -$465K |
|
3125
ProShares UltraPro S&P 500
UPRO
$5.23B
| $2.82M | ﹤0.01% |
59,539
-5,412
| -8% | -$221K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.